Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System [Phase 1]
Phase 1 trial investigating safety and activity of a novel TNFR2 inhibitor in adults with non-Hodgkin lymphoma, including cutaneous T-cell l…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant [Phase 2]
A Phase II randomized trial evaluating hyperbaric oxygen to improve engraftment after umbilical cord blood stem cell transplantation in pati…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma [Phase 4]
Phase 4 trial assessing immunogenicity of a pneumococcal vaccination strategy in adults treated for Non-Hodgkin lymphoma, comparing PCV13+PP…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating venetoclax with BEAM conditioning before autologous stem cell transplant in Non-Hodgkin lymphoma; currentl…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
A clinical trial update describes evaluating 68Ga-Pentixafor PET/MR for detecting lesions in non-Hodgkin lymphoma and multiple myeloma; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL [Phase 2]
Phase 2 clinical trial of Paxalisib (GDC-0084) for recurrent or refractory primary central nervous system lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chemoradiotherapy with targeted immunotherapy for pediatric lymphomas. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating brentuximab vedotin with or without nivolumab in patients with relapsed or refractory C…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL [Phase 1]
Phase 1 study of TAA-specific cytotoxic T lymphocytes (TACTAL) for Hodgkin lymphoma and non-Hodgkin lymphoma; the trial is currently active …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 [EARLY_Phase 1]
A clinical trial update shows STR-P004 for Non-Hodgkin lymphoma is in early Phase 1 and not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers [Phase 1, Phase 2]
A clinical trial update indicates IDP-023 is being studied as a single agent and in combination with antibody therapies in advanced hematolo…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Study of 3D189 in Patients With Hematologic Malignancies [Phase 1]
Phase 1 study of 3D189 in hematologic malignancies is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic CD19-targeting CAR-T cells with SPPL3 gene knockout for relapsed/refractory B-cell lymphoma…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TRAC and SPPL3 gene-knockout allogeneic CD19-targeting CAR-T cells for relapsed/refractory B-cell non-…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
A prospective cohort study on lymphoma sponsored by Samsung Medical Center is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: GVM±R in Patients With Relapsed or Refractory Aggressive NHL [Phase 1]
A Phase 1 trial of GVM±R in relapsed or refractory aggressive non-Hodgkin lymphoma is active but not currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab [Phase 1]
A Phase 1 clinical trial is investigating prophylaxis and treatment of cytokine release syndrome with siltuximab prior to epcoritamab in non…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy [NA]
Clinical trial update on evaluating comprehensive geriatric assessment to predict toxic events in older patients with Non-Hodgkin lymphoma, …
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies [Phase 1]
Phase 1 study of APG-2575 by Ascentage Pharma for chronic lymphocytic leukemia and non-Hodgkin lymphoma is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma. [NA]
This clinical trial update notes recruitment for a study on optimizing radiation dose in diffuse large B-cell lymphoma, a form of non-Hodgki…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients [Phase 1, Phase 2]
Clinical trial update documenting pharmacokinetics, safety, and tolerability assessment of Abexinostat in Chinese patients with Non-Hodgkin …
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies [Phase 1]
Phase 1 study evaluating autologous CD19 CAR-T cell therapy SYNCAR-001 with orthogonal IL-2 STK-009 in CD19-positive hematologic malignancie…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies [Phase 1]
A Phase 1 clinical study evaluating the CD70-targeted agent CHT101 in relapsed or refractory hematologic malignancies is currently recruitin…